CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients.

CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients.

Item
http://www.wikidata.org/entity/Q51328309
Pharmacogenetic studies update in type 2 diabetes mellitusDrug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysisPharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment.Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.The role of genetic factors and kidney and liver function in glycemic control in type 2 diabetes patients on long-term metformin and sulphonylurea cotreatment.Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo populationNLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes PatientsComputational Analysis of Single Nucleotide Polymorphisms Associated with Altered Drug Responsiveness in Type 2 DiabetesCYP2C93 variant is associated with antidiabetes efficacy of gliclazide in Chinese type 2 diabetes patientsGenetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation.Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations.
P2860

CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients.

Item
http://www.wikidata.org/entity/Q51328309
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
CYP2C9, KCNJ11 and ABCC8 polym ...... t in type 2 diabetes patients.
@en
CYP2C9, KCNJ11 and ABCC8 polym ...... t in type 2 diabetes patients.
@nl
type
label
CYP2C9, KCNJ11 and ABCC8 polym ...... t in type 2 diabetes patients.
@en
CYP2C9, KCNJ11 and ABCC8 polym ...... t in type 2 diabetes patients.
@nl
prefLabel
CYP2C9, KCNJ11 and ABCC8 polym ...... t in type 2 diabetes patients.
@en
CYP2C9, KCNJ11 and ABCC8 polym ...... t in type 2 diabetes patients.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
CYP2C9, KCNJ11 and ABCC8 polym ...... t in type 2 diabetes patients.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P921